Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation

Epilepsia

Volumn 48, Issue 6, 2007, Pages 1111-1116

  Tomson, Torbjörn ^a,i   Palm, Ragnar ^b   Källén, Kristina ^c   Ben Menachem, Elinor ^d   Söderfeldt, Birgitta ^e   Danielsson, Bo ^f   Johansson, Rune ^g   Luef, Gerhard ^h   Öhman, Inger ⁱ  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Neurologmottagning Ankaret   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e STOCKHOLM SÖDER HOSPITAL   (Sweden)

^f Mälarsjukhuset ^*  (Sweden)

^g CENTRAL HOSPITAL   (Sweden)

^h UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast milk; Epilepsy; Levetiracetam; Pharmacokinetics; Pregnancy

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; TIAGABINE;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST MILK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DRUG HALF LIFE; EPILEPSY; FEMALE; HUMAN; LACTATION; MOTHER; NEWBORN PERIOD; PLASMA; PREGNANCY; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD;

ANTICONVULSANTS; BREAST FEEDING; DELIVERY, OBSTETRIC; EPILEPSY; FEMALE; FETAL BLOOD; HALF-LIFE; HUMANS; INFANT, NEWBORN; LACTATION; MATERNAL-FETAL EXCHANGE; MILK, HUMAN; PIRACETAM; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; PUERPERAL DISORDERS;

EID: 34249776676     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.01032.x     Document Type: Article

References (14)

1. Allegaert K, Lewi L, Naulaers G, Lagae L 2006) Levetiractam pharmacokinetics in neonates at birth. Epilepsia 47 : 1068 1069.
2. Anderson GD 2005) Pregnancy-induced changes in pharmacokinetics. A mechanistic-based approach. Clinical Pharmacokinetics 44 : 989 1008.
3. Blackburn ST 1994) Renal function in the neonate. Journal of Perinatal and Neonatal Nursing 8 : 37 47.
4. French JA, Kanner AM, Bautista J Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr., Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr., Sachdeo RC, Beydoun A, Glauser TA 2004) Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62 : 1261 1273.
5. Grunewald R 2005) Levetiracetam in the treatment of idiopathic generalized epilepsies. Epilepsia 46 (suppl 9 154 160.
6. Johannessen SI, Helde G, Brodtkorb E 2005) Levetiracetam concentrations in serum and in breast milk at birth and lactation. Epilepsia 46 : 775 777.
7. Krämer G, Hösli I, Glanzmann R (2002) Levetiractem accumulation in human breast milk. Epilepsia 43 (suppl 7 105.
8. Long L 2003) Levetiracetam monotherapy during pregnancy: a case series. Epilepsy and Behaviour 4 : 447 448.
9. Mazzucchelli I, Onat FY, Ozkara C, Atakli P, Specchio LM, La Neve A, Gatti G, Perucca E 2006) Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium. Epilepsia 47 : 504 509.
10. Patsalos PN 2004) Clinical pharmacokinetics of levetiracetam. Clinical Pharmacokinetics 43 : 707 724
11. Pennell PB, Koganti A, Helmers S, Beach A, Newman M, Newport DJ, Stowe ZN 2005) The impact of pregnancy and childbirth on the elimination of levetiracetam. Epilepsia 46 (suppl 8 89.
12. Perucca E, Johannessen SI 2003) The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come? Epileptic Disorders 5 (suppl 1 S17 S26.
13. ten Berg K, Samrén BE, van Oppen AC, Engelsman M, Lindhout D 2005) Levetiracetam use and pregnancy outcome. Reproductive Toxicology 20 : 175 178.
14. Tomson T 2005) Gender aspects of pharmacokinetics of new and old AEDs: Pregnancy and breast-feeding. Therapeutic Drug Monitoring 27 : 718 721.